¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of SABCS in KOREA (San Antonio Breast Cancer Symposium) : 2023-02-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of SABCS in KOREA (San Antonio Breast Cancer Symposium) : 2023-02-04
±³À°ÀÏÀÚ : 2023-02-04
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï ºñ½ºÅ¸È¦  
±³À°ÁÖÁ¦ : Best of SABCS in KOREA (San Antonio Breast Cancer Symposium)
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : meetings@ksmo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ ¿¬±¸¿ø (»çÀü)50,000 (ÇöÀå)60,000 ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/ °øº¸ÀÇ/±ºÀÇ°ü/¾à»ç (»çÀü)30,000 (ÇöÀå)40,000 ¾÷ü ¹× ±âŸ (»çÀü)70,000 (ÇöÀå)80,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-04  09:00~09:25 Updates of basic science and insights into tumor biology  ¹ÚÀÎÇý(°í·Á´ë±¸·Îº´¿ø) 
±³À°½Ã°£ 02-04  09:25~09:50 Spatial Single cell approaches for translational research and biomarker discovery  ±èÁöÇü(°­³²¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 02-04  09:50~10:15 Tumor immunology and novel strategies for immunotherapy  ±èÁö¿¬(»ï¼º¼­¿ïº´¿ø) 
Åä·Ð 02-04  10:15~10:30 Q & A  () 
±³À°½Ã°£ 02-04  10:45~11:10 Updates in surgical management and management of breast cancer risk  ±èÁö¼±(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 02-04  11:10~11:35 Updates in Radiotherapy  ¼ÛÁøÈ£(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 02-04  11:35~11:50 Defining HER2-low disease : Pathologist  À¯ÇѼ®(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 02-04  11:50~12:05 Defining HER2-low disease : Medical oncologist  ¼­°æÁø(ºÐ´ç¼­¿ï´ëº´¿ø) 
Åä·Ð 02-04  12:05~12:20 Q & A  () 
±³À°½Ã°£ 02-04  12:20~13:00 The new leap forward in the treatment of metastatic breast cancer  ¹Ú°æÈ­(°í·Á´ë ±¸·Îº´¿ø) 
±³À°½Ã°£ 02-04  13:30~14:00 Advances in HR+/HER2- Early breast cancer  ÀÌ´ë¿ø(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 02-04  14:00~14:30 Advances in HR+/HER2- Metastatic breast cancer  ÀÌÁöÀº(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 02-04  14:30~14:55 New insights in endocrine resistance and novel endocrine treatment  Ã¤ÈñÁ¤(±¹¸³¾Ï¼¾ÅÍ) 
Åä·Ð 02-04  14:55~15:15 Q & A  () 
±³À°½Ã°£ 02-04  15:30~15:55 HER2-positive breast cancer  ÀÌ°æÀº(ÀÌ´ë¸ñµ¿º´¿ø) 
±³À°½Ã°£ 02-04  15:55~16:20 TNBC and novel therapeutic approaches  ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø) 
Åä·Ð 02-04  16:20~16:30 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of SABCS in KOREA (San Antonio Breast Cancer Symposium) : 2023-02-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÇØ¿î´ë¹éº´¿ø Á¦44ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ¿öÅ©¼¥ : 2023-02-04
´ÙÀ½±Û ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ´ëÀå³»½Ã°æ¿¬±¸È¸ 2023³â Áý´ãȸ : 2023-02-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 33 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 25 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 29 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 40 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 23 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 21 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 24 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 25 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷